Tumor necrosis factor inhibitors: following best practice. [electronic resource]
Producer: 20050713Description: 17-23 p. digitalISSN:- 1062-3388
- Adalimumab
- Anti-Inflammatory Agents -- classification
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Autoimmune Diseases -- drug therapy
- Etanercept
- Formularies as Topic
- Health Maintenance Organizations
- Humans
- Immunoglobulin G -- therapeutic use
- Immunologic Factors -- classification
- Infliximab
- Medicare
- Pharmacy and Therapeutics Committee
- Practice Guidelines as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.